We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · November 30, 2022

Utility of ctDNA for Detecting Minimal Residual Disease Following Curative Surgery in Patients With Colorectal Cancer

British Journal of Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Cancer
The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis
Br. J. Cancer 2022 Nov 08;[EPub Ahead of Print], LG Faulkner, LM Howells, C Pepper, JA Shaw, AL Thomas

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading